Firmicutes

Last updated

Firmicutes
Bacillus subtilis Gram.jpg
Bacillus subtilis , Gram-stained
Scientific classification Red Pencil Icon.png
Domain: Bacteria
(unranked): Terrabacteria
Phylum: Firmicutes
Gibbons and Murray 1978, [1] Murray, 1984 [2]
Classes
Synonyms
  • Endospora
  • Endobacteria Cavalier-Smith 2002
  • "Endobacteria" Cavalier-Smith 1998
  • "Mollifirmicutes"
  • Mollicutes Edward & Freundt 1967
  • Mollicutaeota Oren et al. 2015
  • "Halanaerobiaeota"
  • Tenericutes Murray 1984

The Firmicutes (Latin: firmus, strong, and cutis, skin, referring to the cell wall) are a phylum of bacteria, most of which have gram-positive cell wall structure. [3] A few, however, such as Megasphaera , Pectinatus , Selenomonas and Zymophilus , have a porous pseudo-outer membrane that causes them to stain gram-negative. Scientists once classified the Firmicutes to include all gram-positive bacteria, but have recently defined them to be of a core group of related forms called the low-G+C group, in contrast to the Actinobacteria. They have round cells, called cocci (singular coccus), or rod-like forms (bacillus).

Contents

Many Firmicutes produce endospores, which are resistant to desiccation and can survive extreme conditions. They are found in various environments, and the group includes some notable pathogens. Those in one family, the heliobacteria, produce energy through anoxygenic photosynthesis. Firmicutes play an important role in beer, wine, and cider spoilage.

Classes

The group is typically divided into the Clostridia, which are anaerobic, and the Bacilli, which are obligate or facultative aerobes.

On phylogenetic trees, the first two groups show up as paraphyletic or polyphyletic, as do their main genera, Clostridium and Bacillus . [4] However, Firmicutes as a whole is generally believed to be monophyletic, or paraphyletic with the exclusion of Mollicutes. [5]

Phylogeny

A phylogeny by Annotree [6] and GTDB release 05-RS95 (17 July 2020). [7]

Firmicutes
Firmicutes G

Limnochordia

Firmicutes E

"Thermaerobacteria"

"Symbiobacteriia"

"Sulfobacillia"

"Selenobacteria"

Negativicutes

Firmicutes B

"Syntrophomonadia"

"Dehalobacteriia"

"Peptococcia"

"Desulfitobacteriia"

"Moorellia"

"Thermincolia"

"Desulfotomaculia"

"Halanaerobiaeota"

"Halanaerobiia"

Firmicutes A

"Thermosediminibacteria"

"Thermoanaerobacteria"

"Mahellia"

Clostridiia s.s.

Firmicutes D

"Proteinivoracia"

"Dethiobacteria"

"Natranaerobiia"

"Fusobacteriota"

Fusobacteria

"Bacillota"

"Alicyclobacillia"

"Desulfuribacillia"

"Bacillia" s.s.

This second phylogeny is based on 16S rRNA-based LTP release 132 by the All-Species Living Tree Project, [8] with the currently accepted taxonomy based on the List of Prokaryotic names with Standing in Nomenclature (LPSN), [9] National Center for Biotechnology Information (NCBI), [10] and some non-validated clade names from Genome Taxonomy Database. [11]

"Thermaerobacteria"

Thermaerobacter {"Thermaerobacterales": "Thermaerobacteraceae"}

"Thermoanaerobacteria"

Caldicellulosiruptor {"Caldicellulosiruptorales": "Caldicellulosiruptoraceae"}

"Thermovenabulales"

Dictyoglomus {Dictyoglomaceae}

Tepidanaerobacter {"Tepidanaerobacteraceae"}

"Thermovenabulaceae"

"Ammonificaceae" {"Ammonifexales"}

Thermoanaerobacteraceae {Thermoanaerobacterales}

"Moorellaceae" {"Moorellales"}

"Thermacetogeniaceae" {"Thermacetogeniales"}

Carboxydothermus {"Carboxydothermales": "Carboxydothermaceae"}

"Symbiobacteriia"

Gelria

Symbiobacterium {"Symbiobacteriales": Symbiobacteriaceae}

Sulfobacillus {"Sulfobacillales": "Sulfobacillaceae"}

Clostridia s.s.

Bacillia

Genera

More than 274 genera were considered as of 2016 to be within the Firmicutes phylum,[ citation needed ] notable genera of Firmicutes include:

Bacilli, order Bacillales

Bacilli, order Lactobacillales

Clostridia

Erysipelotrichia

Clinical significance

Firmicutes make up ~30% of the mouse and human gut microbiome. [12] [ failed verification ] The division Firmicutes as part of the gut microbiota has been shown to be involved in energy resorption, and potentially related to the development of diabetes and obesity. [13] [14] [15] [16] Within the gut of healthy human adults, the most abundant bacterium: Faecalibacterium prausnitzii (F. prausnitzii), which makes up 5% of the total gut microbiome, is a member of the Firmicutes phylum. This species is directly associated with reduced low-grade inflammation in obesity. [17] F. prausnitzii has been found in higher levels within the guts of obese children than in non-obese children.

In multiple studies a higher abundance of Firmicutes has been found in obese individuals than in lean controls. A higher level of Lactobacillus (of the Firmicutes phylum) has been found in obese patients and in one study, obese patients put on weight loss diets showed a reduced amount of Firmicutes within their guts. [18]

Diet changes in mice have also been shown to promote changes in Firmicutes abundance. A higher relative abundance of Firmicutes was seen in mice fed a western diet (high fat/high sugar) than in mice fed a standard low fat/ high polysaccharide diet. The higher amount of Firmicutes was also linked to more adiposity and body weight within mice. [19] Specifically, within obese mice, the class Mollicutes (within the Firmicutes phylum) was the most common. When the microbiota of obese mice with this higher Firmicutes abundance was transplanted into the guts of germ-free mice, the germ-free mice gained a significant amount of fat as compared to those transplanted with the microbiota of lean mice with lower Firmicutes abundance. [20]

The presence of Christensenella (Firmicutes, in class Clostridia), isolated from human faeces, has been found to correlate with lower body mass index. [21]

Related Research Articles

Human microbiome Microorganisms in or on human skin and biofluids

The human microbiome is the aggregate of all microbiota that reside on or within human tissues and biofluids along with the corresponding anatomical sites in which they reside, including the skin, mammary glands, seminal fluid, uterus, ovarian follicles, lung, saliva, oral mucosa, conjunctiva, biliary tract, and gastrointestinal tract. Types of human microbiota include bacteria, archaea, fungi, protists and viruses. Though micro-animals can also live on the human body, they are typically excluded from this definition. In the context of genomics, the term human microbiome is sometimes used to refer to the collective genomes of resident microorganisms; however, the term human metagenome has the same meaning.

Mollicutes is a class of bacteria distinguished by the absence of a cell wall. The word "Mollicutes" is derived from the Latin mollis, and cutis. Individuals are very small, typically only 0.2–0.3 μm in size and have a very small genome size. They vary in form, although most have sterols that make the cell membrane somewhat more rigid. Many are able to move about through gliding, but members of the genus Spiroplasma are helical and move by twisting. The best-known genus in the Mollicutes is Mycoplasma.

Clostridia Class of bacteria

The Clostridia are a highly polyphyletic class of Firmicutes, including Clostridium and other similar genera. They are distinguished from the Bacilli by lacking aerobic respiration. They are obligate anaerobes and oxygen is toxic to them. Species of the class Clostridia are often but not always Gram-positive and have the ability to form spores. Studies show they are not a monophyletic group, and their relationships are not entirely certain. Currently, most are placed in a single order called Clostridiales, but this is not a natural group and is likely to be redefined in the future.

Gut microbiota Community of microorganisms in the gut

Gutmicrobiota are the microorganisms including bacteria, archaea and microscopic eukaryotes that live in the digestive tracts of humans and other animals including insects. Alternative terms include gutflora and microbiome. The gastrointestinal metagenome is the aggregate of all the genomes of gut microbiota. The gut is the main location of human microbiota. The gut microbiota has broad impacts, including effects on colonization resistance to pathogens, maintaining the intestinal epithelium, metabolizing dietary and pharmaceutical compounds, controlling immune function, and even behavior thorugh the gut-brain axis.

Fibrobacteres is a small bacterial phylum which includes many of the major rumen bacteria, allowing for the degradation of plant-based cellulose in ruminant animals. Members of this phylum were categorized in other phyla. The genus Fibrobacter was removed from the genus Bacteroides in 1988.

<i>Bacteroides</i> Genus of bacteria

Bacteroides is a genus of Gram-negative, obligate anaerobic bacteria. Bacteroides species are non endospore-forming bacilli, and may be either motile or nonmotile, depending on the species. The DNA base composition is 40–48% GC. Unusual in bacterial organisms, Bacteroides membranes contain sphingolipids. They also contain meso-diaminopimelic acid in their peptidoglycan layer.

Dysbiosis is characterized as a disruption to the microbiota homeostasis caused by an imbalance in the microflora, changes in their functional composition and metabolic activities, or a shift in their local distribution. It is a term for a microbial imbalance or maladaptation on or inside the body, such as an impaired microbiota. For example, a part of the human microbiota, such as the skin flora, gut flora, or vaginal flora, can become deranged, with normally dominating species underrepresented and normally outcompeted or contained species increasing to fill the void. Dysbiosis is most commonly reported as a condition in the gastrointestinal tract, particularly during small intestinal bacterial overgrowth (SIBO) or small intestinal fungal overgrowth (SIFO).

The term "infectobesity" refers to the hypothesis that obesity could have an infectious origin and the emerging field of medical research that studies the relationship between pathogens and weight gain. The term was coined in 2001 by Dr. Nikhil V. Dhurandhar, at the Pennington Biomedical Research Center.

Jeffrey I. Gordon is a biologist and the Dr. Robert J. Glaser Distinguished University Professor and Director of the Center for Genome Sciences and Systems Biology at Washington University in St. Louis. He is internationally known for his research on gastrointestinal development and how gut microbial communities affect normal intestinal function, shape various aspects of human physiology including our nutritional status, and affect predisposition to diseases. He is a member of the National Academy of Sciences, the American Academy of Arts and Sciences, the Institute of Medicine of the National Academies, and the American Philosophical Society.

Microbiota Community of microorganisms

Microbiota are "ecological communities of commensal, symbiotic and pathogenic microorganisms" found in and on all multicellular organisms studied to date from plants to animals. Microbiota include bacteria, archaea, protists, fungi and viruses. Microbiota have been found to be crucial for immunologic, hormonal and metabolic homeostasis of their host. The term microbiome describes either the collective genomes of the microorganisms that reside in an environmental niche or the microorganisms themselves.

Prevotella is a genus of Gram-negative bacteria.

Akkermansia is a genus in the phylum Verrucomicrobia (Bacteria). The genus was first proposed in 2004 by Muriel Derrien and others, with the type species Akkermansia muciniphila.

The Erysipelotrichia are a class of bacteria of the phylum Firmicutes. Species of this class are known to be common in the gut microbiome, as they have been isolated from swine manure and increase in composition of the mouse gut microbiome for mice switched to diets high in fat.

Parasutterella is a genus of Gram-negative, circular/rod-shaped, obligate anaerobic, non-spore forming bacteria from the Proteobacteria phylum, Betaproteobacteria class and the family Sutterellaceae. Previously, this genus was considered "unculturable," meaning that it could not be characterized through conventional laboratory techniques, such as grow in culture due its unique requirements of anaerobic environment. The genus was initially discovered through 16S rRNA sequencing and bioinformatics analysis. By analyzing the sequence similarity, Parasutterella was determined to be related most closely to the genus Sutterella and previously classified in the family Alcaligenaceae.

Skin immunity is a property of skin that allows it to resist infections from pathogens. In addition to providing a passive physical barrier against infection, the skin also contains elements of the innate and adaptive immune systems which allows it to actively fight infections. Hence the skin provides defense in depth against infection.

Akkermansia muciniphila is a species of human intestinal mucin-degrading bacterium, the type species for a new genus, Akkermansia, proposed in 2004 by Muriel Derrien and Willem de Vos. Extensive research is being undertaken to understand its association with obesity, type 2 diabetes, and inflammation.

Microbiota-accessible carbohydrates (MACs) are carbohydrates that are resistant to digestion by a host's metabolism, and are made available for gut microbes, as prebiotics, to ferment or metabolize into beneficial compounds, such as short chain fatty acids. The term, ‘‘microbiota-accessible carbohydrate’’ contributes to a conceptual framework for investigating and discussing the amount of metabolic activity that a specific food or carbohydrate can contribute to a host's microbiota.

The microbiota describes the sum of all symbiotic microorganisms living on or in an organism. The fruit fly Drosophila melanogaster is a model organism and known as one of the most investigated organisms worldwide. The microbiota in flies is less complex than that found in humans. It still has an influence on the fitness of the fly, and it affects different life-history characteristics such as lifespan, resistance against pathogens (immunity) and metabolic processes (digestion). Considering the comprehensive toolkit available for research in Drosophila, analysis of its microbiome could enhance our understanding of similar processes in other types of host-microbiota interactions, including those involving humans. Microbiota plays key roles in the intestinal immune and metabolic responses via their fermentation product, acetate.

Pharmacomicrobiomics

Pharmacomicrobiomics, first used in 2010, is defined as the effect of microbiome variations on drug disposition, action, and toxicity. Pharmacomicrobiomics is concerned with the interaction between xenobiotics, or foreign compounds, and the gut microbiome. It is estimated that over 100 trillion prokaryotes representing more than 1000 species reside in the gut. Within the gut, microbes help modulate developmental, immunological and nutrition host functions. The aggregate genome of microbes extends the metabolic capabilities of humans, allowing them to capture nutrients from diverse sources. Namely, through the secretion of enzymes that assist in the metabolism of chemicals foreign to the body, modification of liver and intestinal enzymes, and modulation of the expression of human metabolic genes, microbes can significantly impact the ingestion of xenobiotics.

Modulibacteria is a bacterial phylum formerly known as KS3B3 or GN06. It is a candidate phylum, meaning there are no cultured representatives of this group. Members of the Modulibacteria phylum are known to cause fatal filament overgrowth (bulking) in high-rate industrial anaerobic wastewater treatment bioreactors.

References

  1. Gibbons, N. E. & Murray, R. G. E. 1978. Proposals concerning the higher taxa of bacteria. Int J Syst Bacteriol 28:1–6, (PDF)
  2. Murray, R. G. E. (1984). The higher taxa, or, a place for everything...?. In: N. R. Krieg & J. G. Holt (ed.) Bergey's Manual of Systematic Bacteriology, vol. 1, The Williams & Wilkins Co., Baltimore, p. 31–34.
  3. " Firmicutes " at Dorland's Medical Dictionary
  4. Wolf M, Müller T, Dandekar T, Pollack JD (May 2004). "Phylogeny of Firmicutes with special reference to Mycoplasma (Mollicutes) as inferred from phosphoglycerate kinase amino acid sequence data". Int. J. Syst. Evol. Microbiol. (Comparative Study). 54 (Pt 3): 871–5. CiteSeerX   10.1.1.126.3863 . doi:10.1099/ijs.0.02868-0. PMID   15143038. Archived from the original on 2012-12-09.
  5. Ciccarelli, FD (2006). "Toward automatic reconstruction of a highly resolved tree of life". Science. 311 (5765): 1283–1287. Bibcode:2006Sci...311.1283C. CiteSeerX   10.1.1.381.9514 . doi:10.1126/science.1123061. PMID   16513982. S2CID   1615592.
  6. Mendler, K; Chen, H; Parks, DH; Hug, LA; Doxey, AC (2019). "AnnoTree: visualization and exploration of a functionally annotated microbial tree of life". Nucleic Acids Research. 47 (9): 4442–4448. doi: 10.1093/nar/gkz246 . PMC   6511854 . PMID   31081040.
  7. "GTDB release 05-RS95". Genome Taxonomy Database .
  8. "16S rRNA-based LTP release 132 (full tree)". All-Species Living Tree Project . Silva Comprehensive Ribosomal RNA Database . Retrieved 2013-03-20.
  9. J. P. Euzéby. "Firmicutes". List of Prokaryotic names with Standing in Nomenclature (LPSN). Archived from the original on January 27, 2013. Retrieved 2013-03-20.
  10. Sayers; et al. "Firmicutes". National Center for Biotechnology Information (NCBI) taxonomy database. Retrieved 24 April 2019.
  11. "GTDB taxonomy". Genome Taxonomy Database . Archived from the original on 2018-07-29. Retrieved 2018-07-20.
  12. Ley RE, Peterson DA, Gordon JI (2006). "Ecological and evolutionary forces shaping microbial diversity in the human intestine". Cell (Review). 124 (4): 837–848. doi: 10.1016/j.cell.2006.02.017 . PMID   16497592. S2CID   17203181.
  13. Ley RE, Turnbaugh PJ, Klein S, Gordon JI (2006). "Microbial ecology: human gut microbes associated with obesity". Nature (Clinical Trial). 444 (7122): 1022–1023. Bibcode:2006Natur.444.1022L. doi:10.1038/4441022a. PMID   17183309. S2CID   205034045.
  14. Henig, Robin Marantz (2006-08-13). "Fat Factors". New York Times Magazine. Retrieved 2008-09-28.
  15. Ley RE, Bäckhed F, Turnbaugh P, Lozupone CA, Knight RD, Gordon JI (August 2005). "Obesity alters gut microbial ecology". Proc. Natl. Acad. Sci. USA (Research Support). 102 (31): 11070–11075. Bibcode:2005PNAS..10211070L. doi: 10.1073/pnas.0504978102 . PMC   1176910 . PMID   16033867.
  16. Komaroff AL. The Microbiome and Risk for Obesity and Diabetes. JAMA. Published online December 22, 2016. doi:10.1001/jama.2016.20099
  17. Chakraborti, Chandra Kanti (15 November 2015). "New-found link between microbiota and obesity". World Journal of Gastrointestinal Pathophysiology. 6 (4): 110–119. doi:10.4291/wjgp.v6.i4.110. PMC   4644874 . PMID   26600968.
  18. Million, M.; Lagier, J.-C; Yahav, D.; Paul, M. (April 2013). "Gut bacterial microbiota and obesity". Clinical Microbiology and Infection. 19 (4): 305–313. doi: 10.1111/1469-0691.12172 . PMID   23452229.
  19. Turnbaugh, Peter J. (17 April 2008). "Diet-Induced Obesity Is Linked to Marked but Reversible Alterations in the Mouse Distal Gut Microbiome". Cell Host & Microbe. 3 (4): 213–223. doi:10.1016/j.chom.2008.02.015. PMC   3687783 . PMID   18407065.
  20. Million, M. (April 2013). "Gut bacterial microbiota and obesity". Cell Microbiology and Infection. 19 (4): 305–313. doi: 10.1111/1469-0691.12172 . PMID   23452229.
  21. Goodrich, Julia K.; Waters, Jillian L.; Poole, Angela C.; Sutter, Jessica L.; Koren, Omry; Blekhman, Ran; Beaumont, Michelle; Van Treuren, William; Knight, Rob; Bell, Jordana T.; Spector, Timothy D.; Clark, Andrew G.; Ley, Ruth E. (2014). "Human Genetics Shape the Gut Microbiome". Cell. 159 (4): 789–799. doi:10.1016/j.cell.2014.09.053. ISSN   0092-8674. PMC   4255478 . PMID   25417156. Open Access logo PLoS transparent.svg